Filing Details
- Accession Number:
- 0001289340-15-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-09 17:10:35
- Reporting Period:
- 2015-06-05
- Filing Date:
- 2015-06-09
- Accepted Time:
- 2015-06-09 17:10:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1289340 | Stereotaxis Inc. | STXS | Electromedical & Electrotherapeutic Apparatus (3845) | 943120386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1267959 | A Fred Middleton | C/O Stereotaxis, Inc. 4320 Forest Park Avenue, Suite 100 St. Louis MO 63108 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-06-05 | 55,476 | $1.69 | 1,200,926 | No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
Common Stock | Disposition | 2015-06-08 | 38,120 | $1.60 | 1,162,806 | No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
Common Stock | Disposition | 2015-06-09 | 13,280 | $1.60 | 1,149,526 | No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
No | 4 | S | Indirect | Sanderling Venture Partners VI Co-Investment Fund, L.P. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 46,810 | Direct | |
Common Stock | 40,673 | Indirect | Sanderling Ventures Management VI |
Common Stock | 6,358 | Indirect | Sanderling VI Limited Partnership |
Common Stock | 5,335 | Indirect | Sanderling VI Beteiligungs GmbH & Co. KG |
Common Stock | 1,500 | Indirect | Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan |
Common Stock | 53,275 | Indirect | Sanderling IV Biomedical Co-Investment Fund, L.P. |
Common Stock | 11,097 | Indirect | Sanderling V Beteiligungs GmbH & Co. KG |
Common Stock | 39,716 | Indirect | Sanderling V Biomedical Co-Investment Fund, L.P. |
Common Stock | 11,956 | Indirect | Sanderling V Limited Partnership |
Common Stock | 67,790 | Indirect | Sanderling Venture Partners V Co-Investment Fund, L.P. |
Common Stock | 22,451 | Indirect | Sanderling Venture Partners IV Co-Investment Fund |
Common Stock | 82 | Indirect | Sanderling Ventures Management V |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.63 to $1.73, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.63, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.62, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.